Skip to content
Search
About Us
About Us
Subscribe
News
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Clinical Trials
COVID
Dermatology
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Immunodeficiencies
Influenza
Insurance Reimbursement
Medicare
Medicines
Mental Health
Therapeutics
Vaccines
Washington Report
Women’s Disorders
Industry Insight
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Chronic Illness
COVID
Dermatology
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Immunodeficiencies
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Mental Health
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Women’s Disorders
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
News
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Clinical Trials
COVID
Dermatology
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Immunodeficiencies
Influenza
Insurance Reimbursement
Medicare
Medicines
Mental Health
Therapeutics
Vaccines
Washington Report
Women’s Disorders
Industry Insight
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Chronic Illness
COVID
Dermatology
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Immunodeficiencies
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Mental Health
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Women’s Disorders
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Home
News
All News
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Clinical Trials
COVID
Dermatology
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Immunodeficiencies
Influenza
Insurance Reimbursement
Medicare
Medicines
Mental Health
Therapeutics
Vaccines
Washington Report
Women’s Disorders
Industry Insight
All Industry Insight
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Chronic Illness
COVID
Dermatology
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Immunodeficiencies
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Mental Health
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Women’s Disorders
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Home
News
All News
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Clinical Trials
COVID
Dermatology
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Immunodeficiencies
Influenza
Insurance Reimbursement
Medicare
Medicines
Mental Health
Therapeutics
Vaccines
Washington Report
Women’s Disorders
Industry Insight
All Industry Insight
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Chronic Illness
COVID
Dermatology
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Immunodeficiencies
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Mental Health
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Women’s Disorders
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Search
Spring 2011 - Safety
Download Issue
Share
Up Front
Publisher's Corner
Spotlight on Safety
By Patrick M. Schmidt
Features
Good Blood
By
Trudie Mitschang
New Transparency Reporting Guidelines Affecting Physicians
By
Jennifer Kester
Risk Evaluation and Mitigation Strategies: An Update
By
Ronale Tucker Rhodes, MS
Promoting Adherence to Therapy
By
Trudie Mitschang
ACOS: Reducing Costs While Improving Quality of Care
By
Ronale Tucker Rhodes, MS
Myths and Facts: Skin Cancer
By
Ronale Tucker Rhodes, MS
BioTrends Watch
Washington Report
GOP Governors Demand More Exchange Flexibility
More Legislation Introduced to Ban Specialty Tiers in States
Hospital Outpatient Reimbursement Increased for 2011
Federal Government Proposes Healthcare Cuts
Medical Tort Reform Legislation Proposed
Reimbursement FAQs
Reimbursement FAQs: Date of Service Billing, Billing Codes, Least Costly Alternatives and More
Industry News
FDA Approves 60-Second HIV Test
Gene Therapy Successful in Treating Immune Disease
FDA Extends Shelf Life of Hizentra to 30 Months
Adults Fall Short on Vaccinations
Autoimmune Skin Disease Is Associated with Neurologic Disease
Prenatal Flu Vaccine May Prevent Flu in Infants
Blood Test May Diagnose Alzheimer’s
Immune Modulation Therapy May Treat Ovarian Cancer
Cancer Vaccine Acceleration Fund Is Launched by CRI
Albuterol Inhalation Solution Voluntarily Recalled from Market
Scientists Discover 600 Fat Species in Human Blood
Breakthrough Made in Cause of Encephalitis
Swine Flu Produces Protective Antibodies Against Other Flu Strains
New Test May Offer Better Cancer Screening
‘Master Switch’ Identified in Inflammatory Diseases
Use of Marijuana Increases Cancer Risk
Canada Approves New Flu Vaccine for Seniors
New Inhaled Drug Protects Against Flu
FDA Approves First Drug to Treat Lupus
BioFocus
Industry Insight
A Fake and a Fraud: Joachim Boldt, MD
By Keith Berman, MPH, MBA
Patient Profile
Early-Onset Alzheimer's: Holding Out Hope
By Trudie Mitschang
BioSources
BioResearch
Human Albumin Reduces Endothelial Dysfunction; Improves Survival in Mouse Model of Sepsis
Influenza Vaccination Reduces Pneumonia Severity During Flu Season
Prophylactic von Willebrand Factor Therapy Reduces Bleeds in Patients with Severe von Willebrand Disease